NCT04621435View on ClinicalTrials.gov

Imaging of Solid Tumors Using FAP-2286

PHASE1RecruitingINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Solid Tumors, AdultMetastatic Cancer
Interventions
DRUG

Gallium-68 labelled (68Ga-) FAP-2286

The dose will be 3 to 8 millicurie (mCi) +/- 10% given intravenously at a single time prior to imaging

PROCEDURE

Positron Emission Tomography (PET) imaging

Participants will be scanned for approximately 30 to 45 minutes

DRUG

Copper-64 labeled (64Cu-) FAP-2286

The dose will be 3.5 to 5.5 millicurie (mCi) +/- 10% given intravenously at a single time prior to imaging

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

Society of Abdominal Radiology

OTHER

lead

Thomas Hope

OTHER